Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

The convention highlighted the importance of comprehensive patient care and early diagnosis in dermatology.

High-dose iron therapy improves anemia without affecting IBD treatment.

Methotrexate is not proven to maintain remission in ulcerative colitis.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

Alopecia areata may be linked to scalp microbiome differences, suggesting potential treatments with prebiotics, probiotics, and postbiotics.

The study's findings are unreliable due to retraction.

Maintaining a balanced scalp microbiome can help reduce itchiness.

Genetic screening for NUDT15 polymorphisms is crucial for patients taking azathioprine, especially in Asians.

Azathioprine is a safe and effective long-term treatment for severe alopecia areata, significantly improving hair regrowth.

Using platelet-rich plasma injections and 5% minoxidil topically can safely and effectively treat mild-to-moderate male pattern baldness.

Three related Persian cats have a rare, likely hereditary skin condition causing hair loss and poor coat quality, with limited treatment options.

Azathioprine caused side effects in over half of the Korean pediatric inflammatory bowel disease patients, requiring close monitoring.

Alopecia areata causes significant stigma and emotional distress, with many affected individuals not receiving adequate support or treatment.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

New vitiligo treatments focus on controlling immune damage and restoring skin color.

JAK inhibitors can effectively reverse hair loss in people with alopecia areata.

JAK inhibitors and platelet-rich plasma show promise for treating alopecia areata.

Two drugs, ritlecitinib and brepocitinib, improved scalp hair loss condition markers.

Alopecia areata is becoming more common in Japan, with a need for better treatments, especially for severe and pediatric cases.

New targeted immunotherapies are improving treatment for inflammatory skin diseases.

Simvastatin/ezetimibe may help some patients with severe alopecia areata regrow hair.

Topical clascoterone may help treat hidradenitis suppurativa.

Biologics and targeted therapies could improve treatment for children with certain chronic skin conditions.

Long-term use of calcineurin inhibitors in transplant patients can cause hormone issues that can be managed with proper care.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Golvatinib shows promise as a treatment for Omicron in elderly patients.

Managing myasthenia gravis is crucial and does not worsen primary Sjögren's syndrome.

Zinc and copper levels may affect erectile dysfunction by influencing hormone levels.

Blocking Janus kinase 1 helps stop inflammation and regrow hair, making it a good treatment for hair loss from alopecia areata.